TITLE

SADHART-CHF: no difference in HF events with sertraline

PUB. DATE
November 2008
SOURCE
Cardiology Today;Nov2008, Vol. 11 Issue 11, p18
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on the Safety and Efficacy of Sertraline for Depression in Patients with Congestive Heart Failure (SADHART-CHF) study which revealed that patients with depression and CHF did not have additional benefit with sertraline. In the trial, Dr. Christopher O'Connor states that sertraline plus nurse-facilitated supportive intervention was equal to nurse-facilitated supportive intervention alone, and that no benefit or harm was seen for nonfatal cardiovascular (CV) events.
ACCESSION #
35639346

 

Related Articles

  • Prognostic Factors for Patients with Congestive Heart Failure -- An Extended Evaluation of the SPICE-Study. Mayer, Benjamin; Holubarsch, Christian; Muche, Rainer; Gaus, Wilhelm // British Journal of Medicine & Medical Research;Oct-Dec2013, Vol. 3 Issue 4, p1952 

    Aims: Controlled clinical trials collect huge amounts of high quality data. It is a waste of information to evaluate these data only for the efficacy and safety of the investigational medication. We propose extended evaluations of large trials for scientific purposes, especially to find the most...

  • Advances in CHF treatment: From clinical trial to the community. Pinkowish, Mary Desmond // Patient Care;3/15/1999, Vol. 33 Issue 5, p23 

    Relates the results of a study conducted suggesting that advances in the treatment of congestive heart failure derived from clinical trials have not translated into gains among patients in the community. Low dosage of angiotensin-converting enzyme inhibitors given community patients; Evidence...

  • β-Blockers in Heart Failure: The ‘New Wave’ of Clinical Trials. Krum, H. // Drugs;Aug1999, Vol. 58 Issue 2, p203 

    There is now considerable clinical trial data to support the use of β-blockers in patients with congestive heart failure (CHF) due to systolic left ventricular dysfunction. A substantial database has accumulated over the last 20 years supporting the benefits of these agents on ventricular...

  • High Dose Hawthorn Extract for Advanced Congestive Heart Failure. Brown, Donald J. // HerbalGram;Winter2002, Issue 57, p1 

    Reports on a randomized and placebo-controlled clinical trial in New York to study the efficacy of standardized hawthorn leaves with flower extract in patients with congestive heart failure. Assessment of exercise capacity using seated bicycle ergometry with incremental increase in workload;...

  • Sweat Your Heart? Sauna for CHF. Greenfeld, Russell H. // Alternative Medicine Alert;Feb2012, Vol. 15 Issue 2, p20 

    THE RESEARCHERS BEHIND THIS CLINICAL INTERVENTION trial sought to assess the impact of Waon therapy (repeated sauna therapy) on exercise tolerance in people with congestive heart failure (CHF). Subjects had to have stable, compensated NYHA functional class II heart failure and/or previous...

  • Primary cardiac sarcoma presenting as acute left-sided heart failure. Pathak, Ranjan; Nepal, Santosh; Giri, Smith; Ghimire, Sushil; Aryal, Madan Raj // Journal of Community Hospital Internal Medicine Perspectives (JC;2014, Vol. 4 Issue 3, p1 

    Primary cardiac sarcomas are rare malignant tumors of the heart. Clinical features depend on the site of tumor and vary from symptoms of congestive heart failure to thromboembolism and arrhythmias. Echocardiography is helpful but definitive diagnosis is established by histopathology. Surgical...

  • Vasopressin was not better than epinephrine for out-of-hospital cardiac arrest. Worster, Andrew // ACP Journal Club;Jul/Aug2004, Vol. 141 Issue 1, p2 

    The article presents an overview of whether for patients with out-of-hospital cardiac arrest, vasopressin more effective than epinephrine for survival to hospital admission. The rate of hospital admission was not higher among patients who received vasopressin than those who received epinephrine....

  • Northern Territory Perspectives on Heart Failure with Comorbidities – Understanding Trial Validity and Exploring Collaborative Opportunities to Broaden the Evidence Base. Iyngkaran, P.; Majoni, W.; Cass, A.; Sanders, Prashanthan; Ronco, C.; Brady, S.; Kangaharan, N.; Ilton, M.; Hare, D.L.; Thomas, M.C. // Heart, Lung & Circulation;Jun2015, Vol. 24 Issue 6, p536 

    Congestive Heart Failure (CHF) is an ambulatory care sensitive condition, associated with significant morbidity and mortality, rarely with cure. Outpatient based pharmacological management represents the main and most important aspect of care, and is usually lifelong. This narrative styled...

  • A question of balance. Ramchandani, Paul // Nature;7/22/2004, Vol. 430 Issue 6998, p401 

    Focuses on the concerns of drug safety for the treatment of depression of adolescents. Percentage rate of off-license drugs used to treat children; Lack of transparency of the results of the clinical trials conducted by pharmaceutical company; Details of information on cognitive behavior therapy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics